Vcanbio Cell & Gene Engineering Corp., Ltd — Investor Relations & Filings
About Vcanbio Cell & Gene Engineering Corp., Ltd
Vcanbio Cell & Gene Engineering Corp., Ltd. specializes in the fields of cell therapy, gene technology, and precision medicine. The company operates a comprehensive business model centered on the storage of hematopoietic and mesenchymal stem cells, providing long-term bio-banking services for cord blood and other biological tissues. Its technical portfolio includes advanced genetic testing services, such as prenatal screening and oncology diagnostics, alongside the development of cell-based therapeutic products. Vcanbio maintains a network of specialized laboratories and storage facilities to support clinical research and personalized healthcare applications. The organization focuses on translating biotechnological advancements into clinical solutions, emphasizing quality control in cell processing and genomic analysis to serve the evolving needs of the regenerative medicine and diagnostic sectors.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 中源协和细胞基因工程股份有限公司2025年年度股东会会议资料 | 2026-05-08 | Chinese | |
| 中源协和细胞基因工程股份有限公司董事会审计委员会对会计师事务所履行监督职责情况报告 | 2026-04-24 | Chinese | |
| 中源协和细胞基因工程股份有限公司对外提供财务资助管理办法 | 2026-04-24 | Chinese | |
| 中源协和细胞基因工程股份有限公司关于公司2025年度募集资金存放、管理与实际使用情况的专项报告 | 2026-04-24 | Chinese | |
| 中源协和细胞基因工程股份有限公司董事、高级管理人员薪酬管理制度 | 2026-04-24 | Chinese | |
| 独立董事候选人声明与承诺（张业炎） | 2026-04-24 | Chinese |
Browse filings by year
27 years- 2026 28 filings
- 2025 103 filings
- 2024 87 filings
- 2023 92 filings
- 2022 101 filings
- 2021 86 filings
- 2020 149 filings
- 2019 146 filings
- 2018 291 filings
- 2017 200 filings
- 2016 199 filings
- 2015 194 filings
- 2014 206 filings
- 2013 72 filings
- 2012 105 filings
- 2011 52 filings
- 2010 81 filings
- 2009 62 filings
- 2008 57 filings
- 2007 67 filings
- 2006 61 filings
- 2005 26 filings
- 2004 32 filings
- 2003 36 filings
- 2002 33 filings
- 2001 9 filings
- 1993 1 filing
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 44493056 | 中源协和细胞基因工程股份有限公司2025年年度股东会会议资料 | 2026-05-08 | Chinese | ||
| 41331938 | 中源协和细胞基因工程股份有限公司董事会审计委员会对会计师事务所履行监督职责情况报告 | 2026-04-24 | Chinese | ||
| 41331932 | 中源协和细胞基因工程股份有限公司对外提供财务资助管理办法 | 2026-04-24 | Chinese | ||
| 41331925 | 中源协和细胞基因工程股份有限公司关于公司2025年度募集资金存放、管理与实际使用情况的专项报告 | 2026-04-24 | Chinese | ||
| 41331911 | 中源协和细胞基因工程股份有限公司董事、高级管理人员薪酬管理制度 | 2026-04-24 | Chinese | ||
| 41331904 | 独立董事候选人声明与承诺（张业炎） | 2026-04-24 | Chinese | ||
| 41331902 | 中源协和细胞基因工程股份有限公司2025年年度报告 | 2026-04-24 | Chinese | ||
| 41331900 | 中源协和细胞基因工程股份有限公司关于会计政策变更的公告 | 2026-04-24 | Chinese | ||
| 41331895 | 中源协和细胞基因工程股份有限公司重大风险和突发事件预警与应急处理制度 | 2026-04-24 | Chinese | ||
| 41331885 | 中源协和细胞基因工程股份有限公司内幕信息知情人管理制度 | 2026-04-24 | Chinese | ||
| 41331876 | 中源协和细胞基因工程股份有限公司关于计提资产减值损失的公告 | 2026-04-24 | Chinese | ||
| 41331863 | 中源协和细胞基因工程股份有限公司审计报告 | 2026-04-24 | Chinese | ||
| 41330857 | 中源协和细胞基因工程股份有限公司防范控股股东、实际控制人及其他关联方占用资金管理制度 | 2026-04-24 | Chinese | ||
| 41330846 | 中源协和细胞基因工程股份有限公司对会计师事务所履职情况的评估报告 | 2026-04-24 | Chinese | ||
| 41330844 | 中源协和细胞基因工程股份有限公司2025年度独立董事述职报告（罗明生） | 2026-04-24 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Eurofins-Cerep
Contract research organization for pre-clinical in vitro dr…
|
ALECR | FR | Professional, scientific and te… |
|
Evaxion A/S
A clinical-stage TechBio company developing immunotherapies…
|
EVAX | US | Professional, scientific and te… |
|
Evogene Ltd.
A computational biology company using AI to develop life-sc…
|
EVGN | IL | Professional, scientific and te… |
|
EvokAI Creative Labs Inc.
AI-powered MedTech company analyzing medical data and devel…
|
OKAI | CA | Professional, scientific and te… |
|
Evotec SE
A life science company offering drug discovery and developm…
|
EVT | DE | Professional, scientific and te… |
|
EXICURE, INC.
Early-stage biotech developing nucleic acid therapies based…
|
XCUR | US | Professional, scientific and te… |
|
EyeGene,Inc
Develops gene/cell therapies for age-related diseases and p…
|
185490 | KR | Professional, scientific and te… |
|
Femtobiomed Inc.
Develops a non-viral intracellular delivery platform for ce…
|
327610 | KR | Professional, scientific and te… |
|
Fermi Inc.
Develops AI data center campuses with co-located hybrid pow…
|
FRMI | US | Professional, scientific and te… |
|
Fluicell AB
A biotech firm creating engineered tissues for regenerative…
|
FLUI | SE | Professional, scientific and te… |
Vcanbio Cell & Gene Engineering Corp., Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/56891/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=56891 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=56891 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=56891 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 56891}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Vcanbio Cell & Gene Engineering Corp., Ltd (id: 56891)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.